Literature DB >> 19497526

Call to action to prevent venous thromboembolism.

Thomas W Wakefield1, Robert B McLafferty, Joann M Lohr, Joseph A Caprini, David L Gillespie, Marc A Passman.   

Abstract

Deep venous thrombosis and pulmonary embolism, together called venous thromboembolism, remain a serious national health problem. Estimates suggest that over 900,000 cases occur in the United States per year, with 300,000 deaths per year. Because of the significant and serious nature of this problem, a workshop was held in May of 2006, which resulted in the Acting U.S. Public Health Service Surgeon General's Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism. On September 15, 2008, Acting Surgeon General, Rear Admiral Steven K. Galson, MD, MPH, and Elizabeth Nabel, MD, Director National Heart, Lung, and Blood Institute, announced the Call to Action. The Call to Action highlights public awareness about the risk factors, triggering events, and symptoms of venous thrombosis and pulmonary embolism, and encourages the development of evidence based practices for screening, prevention, diagnosis, and treatment of venous thrombosis and pulmonary embolism. It is designed to encourage new scientific investigation in an effort to obtain needed evidence to fill in the gaps of knowledge about venous thrombosis and pulmonary embolism. This knowledge should be quickly and easily disseminated to the public and put into practice by health professionals. The Surgeon General's Call to Action represents one of the most important advances in the field of venous thromboembolism and sets the stage for multidisciplinary efforts to combat this serious national health problem.

Entities:  

Mesh:

Year:  2009        PMID: 19497526     DOI: 10.1016/j.jvs.2009.01.058

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  23 in total

1.  Validation of the Caprini risk assessment model in plastic and reconstructive surgery patients.

Authors:  Christopher J Pannucci; Steven H Bailey; George Dreszer; Christine Fisher Wachtman; Justin W Zumsteg; Reda M Jaber; Jennifer B Hamill; Keith M Hume; J Peter Rubin; Peter C Neligan; Loree K Kalliainen; Ronald E Hoxworth; Andrea L Pusic; Edwin G Wilkins
Journal:  J Am Coll Surg       Date:  2010-11-18       Impact factor: 6.113

Review 2.  Comparison of All-Cause Mortality Following VTE Treatment Between Propensity Score-Adjusted Observational Studies and Matched Randomized Controlled Trials: Meta-Epidemiologic Study.

Authors:  Claudia Coscia; Ana Jaureguizar; Carlos Andres Quezada; Alfonso Muriel; Manuel Monreal; Tomas Villén; Esther Barbero; Diana Chiluiza; Roger D Yusen; David Jimenez
Journal:  Chest       Date:  2018-10-25       Impact factor: 9.410

3.  Venous thromboembolism risk factor assessment and prophylaxis.

Authors:  P K Henke; C J Pannucci
Journal:  Phlebology       Date:  2010-10       Impact factor: 1.740

4.  The effect of postoperative enoxaparin on risk for reoperative hematoma.

Authors:  Christopher J Pannucci; Christine Fisher Wachtman; George Dreszer; Steven H Bailey; Pamela R Portschy; Jennifer B Hamill; Keith M Hume; Ronald E Hoxworth; Loree K Kalliainen; J Peter Rubin; Andrea L Pusic; Edwin G Wilkins
Journal:  Plast Reconstr Surg       Date:  2012-01       Impact factor: 4.730

5.  Modelling platelet-blood flow interaction using the subcellular element Langevin method.

Authors:  Christopher R Sweet; Santanu Chatterjee; Zhiliang Xu; Katharine Bisordi; Elliot D Rosen; Mark Alber
Journal:  J R Soc Interface       Date:  2011-05-18       Impact factor: 4.118

Review 6.  Venous Thrombosis and Post-Thrombotic Syndrome: From Novel Biomarkers to Biology.

Authors:  Allan K Metz; Jose A Diaz; Andrea T Obi; Thomas W Wakefield; Daniel D Myers; Peter K Henke
Journal:  Methodist Debakey Cardiovasc J       Date:  2018 Jul-Sep

7.  Changing practice: implementation of a venous thromboembolism prophylaxis protocol at an academic medical center.

Authors:  Christopher J Pannucci; Reda M Jaber; Justin M Zumsteg; Vlad Golgotiu; Lisa M Spratke; Edwin G Wilkins
Journal:  Plast Reconstr Surg       Date:  2011-11       Impact factor: 4.730

Review 8.  Critical review of mouse models of venous thrombosis.

Authors:  Jose A Diaz; Andrea T Obi; Daniel D Myers; Shirley K Wrobleski; Peter K Henke; Nigel Mackman; Thomas W Wakefield
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-03       Impact factor: 8.311

9.  Procedure-specific venous thromboembolism prophylaxis: a paradigm from colectomy surgery.

Authors:  Peter K Henke; Shipra Arya; Chris Pannucci; Jim Kubus; Samantha Hendren; Michael Engelsbe; Darrell Campbell
Journal:  Surgery       Date:  2012-10       Impact factor: 3.982

10.  National and Regional Trends in Deep Vein Thrombosis Hospitalization Rates, Discharge Disposition, and Outcomes for Medicare Beneficiaries.

Authors:  Karl E Minges; Behnood Bikdeli; Yun Wang; Robert R Attaran; Harlan M Krumholz
Journal:  Am J Med       Date:  2018-06-23       Impact factor: 4.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.